Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Banque Pictet & Cie SA cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 35.3% in the third quarter, HoldingsChannel reports. The firm owned 1,545 shares of the biopharmaceutical company’s stock after selling 844 shares during the quarter. Banque Pictet & Cie SA’s holdings in Regeneron Pharmaceuticals were worth $1,271,000 at the […]
Avitas Wealth Management LLC lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 531 shares of the biopharmaceutical company’s stock after selling 19 shares during […]
Nisa Investment Advisors LLC reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,633 shares of the biopharmaceutical company’s stock after selling 1,082 shares during the […]
Daiwa Securities Group Inc. raised its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,572 shares of the biopharmaceutical company’s stock after purchasing an additional 1,892 shares during the quarter. […]
Royal Bank of Canada upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a sector perform rating to an outperform rating in a report released on Friday, MarketBeat Ratings reports. They currently have $1,076.00 price target on the biopharmaceutical company’s stock, up from their previous price target of $884.00. Several other research firms also […]